Clinical Trials Directory

Trials / Completed

CompletedNCT04024371

Validating Reward-related Biomarkers (RTOC)

Validating Reward-related Biomarkers to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
160 (actual)
Sponsor
Maastricht University · Academic / Other
Sex
All
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

Deficits or abnormalities in reward processing are present in a number of psychiatric disorders. The overarching objective of the study is to conduct initial validation work towards optimising three experimental tasks - which have previously been shown to be sensitive to reward processing deficits - for future use in clinical trials. This initial validation work has the primary objective to uncover group differences in task outcome measures between healthy control participants, participants with Major Depressive Disorder (MDD) and participants with schizophrenia (SZ) using statistical analyses. This may provide some indications for the use of these tasks as clinically-relevant biomarkers. Primary aims include: (i) comparing the investigator's endpoint means and distributions to those in previously published data; (ii) replication of previously-reported differences between MDD/SZ vs. healthy control participants, and, (iii) exploring the relationship between task endpoints and subjective participant- and clinician-rated report of reward-related constructs (e.g. anhedonia, negative symptoms).

Conditions

Interventions

TypeNameDescription
BEHAVIORALSelf-rating Questionnaires* Snaith-Hamilton Pleasure Scale (SHAPS; Snaith et al. 1995) * Quick Inventory of Depressive Symptomatology (QIDS; 16 items) * Behavioral avoidance/inhibition Scales (BIS/BAS)
BEHAVIORALMeasures of Reward processing/reinforcement learning* Grip Strength Effort Task (Reddy et al. 2015; in combination with EEG) * Doors (Gambling) task (Foti and Hajcak 2009; in combination with EEG) * Reinforcement Learning/Working Memory task (Collins et al. 2017; no EEG)
BEHAVIORALAdditional Schizophrenia-specific Questionnaires and Interviews* Positive and Negative Syndrome Scale (PANSS: Kay et al. 1987) * Brief Negative Symptom Scale (BNSS; Kirkpatrick et al. 2011)

Timeline

Start date
2019-09-16
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2019-07-18
Last updated
2022-07-26

Locations

4 sites across 4 countries: Germany, Greece, Netherlands, Spain

Source: ClinicalTrials.gov record NCT04024371. Inclusion in this directory is not an endorsement.